In the present study, four (17%) out of 24 patients harbored germline pathogenic variants including BRCA1, BRCA2, or PTEN. All four patients with germline pathogenic variants had family members with breast and/or ovarian cancers, whereas germline pathogenic variants were not detected in patients with endocrine-responsive disease. The gene discussed is BRCA1; the disease is ovarian cancer.